Designing development programs for non-traditional antibacterial agents
Rex, John H, Fernandez Lynch, Holly, Cohen, I Glenn, Darrow, Jonathan J, Outterson, Kevin
Published in Nature communications (31.07.2019)
Published in Nature communications (31.07.2019)
Get full text
Journal Article
New FDA Breakthrough-Drug Category — Implications for Patients
Darrow, Jonathan J, Avorn, Jerry, Kesselheim, Aaron S
Published in The New England journal of medicine (27.03.2014)
Published in The New England journal of medicine (27.03.2014)
Get full text
Journal Article
Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
Darrow, Jonathan J, Sarpatwari, Ameet, Avorn, Jerry, Kesselheim, Aaron S
Published in The New England journal of medicine (15.01.2015)
Published in The New England journal of medicine (15.01.2015)
Get full text
Journal Article
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings
Egilman, Alexander C, Van de Wiele, Victor L, Rome, Benjamin N, Darrow, Jonathan J, Tu, S Sean, Kesselheim, Aaron S, Sarpatwari, Ameet
Published in JAMA internal medicine (01.01.2023)
Published in JAMA internal medicine (01.01.2023)
Get more information
Journal Article
FDA Approval and Regulation of Pharmaceuticals, 1983-2018
Darrow, Jonathan J, Avorn, Jerry, Kesselheim, Aaron S
Published in JAMA : the journal of the American Medical Association (14.01.2020)
Published in JAMA : the journal of the American Medical Association (14.01.2020)
Get full text
Journal Article
FDA Regulation and Approval of Medical Devices: 1976-2020
Darrow, Jonathan J, Avorn, Jerry, Kesselheim, Aaron S
Published in JAMA : the journal of the American Medical Association (03.08.2021)
Published in JAMA : the journal of the American Medical Association (03.08.2021)
Get full text
Journal Article
Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
Kesselheim, Aaron S, Wang, Bo, Franklin, Jessica M, Darrow, Jonathan J
Published in BMJ (Online) (23.09.2015)
Published in BMJ (Online) (23.09.2015)
Get full text
Journal Article
The FDA Breakthrough-Drug Designation — Four Years of Experience
Darrow, Jonathan J, Avorn, Jerry, Kesselheim, Aaron S
Published in The New England journal of medicine (12.04.2018)
Published in The New England journal of medicine (12.04.2018)
Get full text
Journal Article
Communication of Drug Efficacy Information via a Popular Online Platform
Darrow, Jonathan J., Borisova, Elizaveta
Published in Journal of the American Board of Family Medicine (01.07.2022)
Published in Journal of the American Board of Family Medicine (01.07.2022)
Get full text
Journal Article
The US Biosimilar Market: Stunted Growth and Possible Reforms
Sarpatwari, Ameet, Barenie, Rachel, Curfman, Gregory, Darrow, Jonathan J, Kesselheim, Aaron S
Published in Clinical pharmacology and therapeutics (01.01.2019)
Published in Clinical pharmacology and therapeutics (01.01.2019)
Get more information
Journal Article
Efficacy and costs of spinal muscular atrophy drugs
Darrow, Jonathan J, Sharma, Monica, Shroff, Mansa, Wagner, Anita K
Published in Science translational medicine (11.11.2020)
Published in Science translational medicine (11.11.2020)
Get more information
Journal Article
Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling
Gyawali, Bishal, Darrow, Jonathan J, Kesselheim, Aaron S
Published in JAMA internal medicine (01.07.2021)
Published in JAMA internal medicine (01.07.2021)
Get more information
Journal Article